Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387157064> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4387157064 endingPage "4412" @default.
- W4387157064 startingPage "4403" @default.
- W4387157064 abstract "Background/Aim: Hepatocellular carcinoma (HCC) is a primary liver cancer with limited treatment options and poor prognosis. Regorafenib, a multi-kinase inhibitor, has shown promise in HCC treatment; however, its efficacy can be enhanced by combining it with other agents. 18β-glycyrrhetinic acid (18β-gly) is a natural compound with potential anti-cancer properties. Materials and Methods: The toxicity and mechanism of regorafenib and 18β-gly was assessed on Hep3B cells, Huh7 cells, and Hep3B bearing animal model. Results: The combination of regorafenib and 18β-gly exhibited synergistic toxicity in HCC cells and animal model. Importantly, no significant differences in body weight or major tissue damage were observed after treatment with the combination of two drugs. Furthermore, the combination treatment modulated apoptosis-related markers and the mTOR signaling pathway. Conclusion: The study provides evidence for the synergistic effect of 18β-gly and regorafenib in a HCC model. The combination treatment modulated apoptosis-related markers and the mTOR signaling pathway, highlighting potential mechanisms underlying its therapeutic efficacy." @default.
- W4387157064 created "2023-09-30" @default.
- W4387157064 creator A5001944455 @default.
- W4387157064 creator A5007195542 @default.
- W4387157064 creator A5017068591 @default.
- W4387157064 creator A5034426865 @default.
- W4387157064 creator A5042931408 @default.
- W4387157064 creator A5044591991 @default.
- W4387157064 creator A5069118972 @default.
- W4387157064 creator A5087484649 @default.
- W4387157064 date "2023-09-29" @default.
- W4387157064 modified "2023-10-11" @default.
- W4387157064 title "Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid" @default.
- W4387157064 doi "https://doi.org/10.21873/anticanres.16636" @default.
- W4387157064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37772586" @default.
- W4387157064 hasPublicationYear "2023" @default.
- W4387157064 type Work @default.
- W4387157064 citedByCount "0" @default.
- W4387157064 crossrefType "journal-article" @default.
- W4387157064 hasAuthorship W4387157064A5001944455 @default.
- W4387157064 hasAuthorship W4387157064A5007195542 @default.
- W4387157064 hasAuthorship W4387157064A5017068591 @default.
- W4387157064 hasAuthorship W4387157064A5034426865 @default.
- W4387157064 hasAuthorship W4387157064A5042931408 @default.
- W4387157064 hasAuthorship W4387157064A5044591991 @default.
- W4387157064 hasAuthorship W4387157064A5069118972 @default.
- W4387157064 hasAuthorship W4387157064A5087484649 @default.
- W4387157064 hasConcept C121608353 @default.
- W4387157064 hasConcept C126322002 @default.
- W4387157064 hasConcept C143998085 @default.
- W4387157064 hasConcept C190283241 @default.
- W4387157064 hasConcept C197934379 @default.
- W4387157064 hasConcept C2776231280 @default.
- W4387157064 hasConcept C2776248978 @default.
- W4387157064 hasConcept C2776999253 @default.
- W4387157064 hasConcept C2778019345 @default.
- W4387157064 hasConcept C29730261 @default.
- W4387157064 hasConcept C502942594 @default.
- W4387157064 hasConcept C526805850 @default.
- W4387157064 hasConcept C55493867 @default.
- W4387157064 hasConcept C71924100 @default.
- W4387157064 hasConcept C86554907 @default.
- W4387157064 hasConcept C86803240 @default.
- W4387157064 hasConcept C98274493 @default.
- W4387157064 hasConceptScore W4387157064C121608353 @default.
- W4387157064 hasConceptScore W4387157064C126322002 @default.
- W4387157064 hasConceptScore W4387157064C143998085 @default.
- W4387157064 hasConceptScore W4387157064C190283241 @default.
- W4387157064 hasConceptScore W4387157064C197934379 @default.
- W4387157064 hasConceptScore W4387157064C2776231280 @default.
- W4387157064 hasConceptScore W4387157064C2776248978 @default.
- W4387157064 hasConceptScore W4387157064C2776999253 @default.
- W4387157064 hasConceptScore W4387157064C2778019345 @default.
- W4387157064 hasConceptScore W4387157064C29730261 @default.
- W4387157064 hasConceptScore W4387157064C502942594 @default.
- W4387157064 hasConceptScore W4387157064C526805850 @default.
- W4387157064 hasConceptScore W4387157064C55493867 @default.
- W4387157064 hasConceptScore W4387157064C71924100 @default.
- W4387157064 hasConceptScore W4387157064C86554907 @default.
- W4387157064 hasConceptScore W4387157064C86803240 @default.
- W4387157064 hasConceptScore W4387157064C98274493 @default.
- W4387157064 hasIssue "10" @default.
- W4387157064 hasLocation W43871570641 @default.
- W4387157064 hasLocation W43871570642 @default.
- W4387157064 hasOpenAccess W4387157064 @default.
- W4387157064 hasPrimaryLocation W43871570641 @default.
- W4387157064 hasRelatedWork W2054301472 @default.
- W4387157064 hasRelatedWork W2314601331 @default.
- W4387157064 hasRelatedWork W2319024198 @default.
- W4387157064 hasRelatedWork W2592068656 @default.
- W4387157064 hasRelatedWork W2624771607 @default.
- W4387157064 hasRelatedWork W2811168026 @default.
- W4387157064 hasRelatedWork W3091350106 @default.
- W4387157064 hasRelatedWork W4293577346 @default.
- W4387157064 hasRelatedWork W4380224996 @default.
- W4387157064 hasRelatedWork W4387157064 @default.
- W4387157064 hasVolume "43" @default.
- W4387157064 isParatext "false" @default.
- W4387157064 isRetracted "false" @default.
- W4387157064 workType "article" @default.